Skip to main content
. 2016 May 3;54(11):924–932. doi: 10.1038/sc.2016.58

Figure 3.

Figure 3

A dose–response experiment with different concentrations of Etamsylate. (ad) Dashed lines indicate the lesion boundary defined by GFAP-immunoreactive astrocytic scar in glucose (a), 0.025 g kg−1 (b), 0.05 g kg−1 (c) and 0.1 g kg−1 groups (d). Scale bars=300 μm. (e) Quantification of lesion area; n=6/group. *P<0.05.